Technological and Patent Evolution of Murine Monoclonal Antibodies
Journal Title: Journal of Advances in Biology & Biotechnology - Year 2017, Vol 14, Issue 2
Abstract
Among the pharmaceutical products targeted for patent protection, monoclonal antibodies stand out. Technological advances involving monoclonal antibodies aim to minimize detrimental human immune responses to antibodies (e.g., human anti-murine antibodies [HAMA]) and increase the binding affinity of antibodies to their antigen, making them more specific for their therapeutic target. This work evaluates the main technological advances pertaining to monoclonal antibodies, from the creation of technology for the immortalization of cells to generate hybridomas through the generation of chimeric and humanized antibodies by genetic engineering techniques, phage display technology, and transgenic mice. It also aims to provide an overview of commercially available and patented murine monoclonal antibodies and to correlate the main players, markets, and therapeutic uses for which the antibodies were developed. The study of mMAB (murine monoclonal antibodies) proved to be of great importance to understand how the development of these antibodies and their protection by patents affects their therapeutic use in cancer patients, in diagnostics, to treat inflammation, etc. The United States (US), Japan (JP), France (FR), and China (CN) constitute potential markets for these protected technological advances. Among current usage trends of three murine monoclonal antibodies whose patents have expired, the use of generic and/or biosimilar is evidenced, as well as the use of these assets to guarantee the protection of new products, new associated processes (e.g., new combinations, associations, or dosage forms), or new processes. The newest market trends related to patent protection in this technological area incorporate the use of monoclonal antibody fragments.
Authors and Affiliations
Kátia dos Reis, José Procópio Moreno Senna, Nei Pereira Júnior, Maria Antonieta Peixoto Gimenes Couto
Keywords
Related Articles
- EP ID EP318148
- DOI 10.9734/JABB/2017/34759
- Views 85
- Downloads 0
Evolution of Lipid Oxidation in Syrian Olive Oil under Irradiation and Storage
Aims: The current study examines variations in Syrian olive oil (SOO) after gamma irradiation treatment and during storage. Study Design: Four irradiation treatments (0, 1, 2 and 3 kGy) were distributed in a completely...
Caffeine and Cannabis Effects on the Cerebellar Cortex of Juvenile Rats
Caffeine and cannabis are two of the world most popularly consumed psychoactive substances. While caffeine is consumed with little or no regulation and restrictions in moist of the countries of the world; cannabis safety...
Techniques for the Enrichment of Micronutrients in Crops through Biofortification: A Review
Deficiency of micronutrients such as iron, zinc, selenium and vitamin A affect human health globally. This deficiency is being controlled by supplementation and nutrient fortification, however, new alternatives ar...
Total Phenols, Antioxidant Capacity and Antibacterial Activity of Manuka Honey Chemical Constituents
Aims: To compare the total phenol content, antioxidant capacity and antibacterial activity of methyl syringate (MSY), methylglyoxal (MGO) and phenyllactic acid (PLA) as major components from Manuka honey Study Design: In...
Kolaviron Reduces Cadmium-induced Cytotoxicity and Production of Reactive Oxygen Species by Suppressing Inflammatory Response
The effect of kolaviron (a bi-flavonoid complex extracted from Garcinia kola) on cadmium (Cd)-induced cell death/ production of reactive oxygen species (ROS) in monocyte U937 cells and production of inflammatory markers/...